Shoulder Innovations Inc
SI15.550USD
+0.230+1.50%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
320.09MMarket Cap
LossP/E TTM
More Details of Shoulder Innovations Inc Company
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on transforming the shoulder surgical care market. The Company offers advanced implant systems for shoulder arthroplasty. These systems are a core element of its ecosystem, designed to improve the core components of shoulder surgical care, preoperative planning, implant design and procedural efficiency, to benefit each stakeholder in the care chain. Its ecosystem is also comprised of enabling technologies, instrument systems, specialized support and surgeon-to-surgeon collaboration. Its advanced implants are comprised of its aTSA and rTSA systems, which are designed to address the needs of patients and surgeons, and include various, specifically designed components capable of an array of system configurations to facilitate different modes of operation (anatomic or reverse). Its InSet Glenoid technology serves as the foundation for its advanced implant systems and includes a novel InSet design.
Shoulder Innovations Inc Info
Ticker SymbolSI
Company nameShoulder Innovations Inc
IPO dateJul 31, 2025
CEOBall (Robert Joseph)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJul 31
Address1535 Steele Avenue Sw, Suite B
CityGRAND RAPIDS
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code49507
Phone16165660286
Websitehttps://shoulderinnovations.com/
Ticker SymbolSI
IPO dateJul 31, 2025
CEOBall (Robert Joseph)
Company Executives of Shoulder Innovations Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Matt Ahearn
Mr. Matt Ahearn
Chief Operating Officer, Director
Chief Operating Officer, Director
282.62K
+61.24%
Mr. David L. Blue
Mr. David L. Blue
Chief Customer Experience Officer
Chief Customer Experience Officer
182.27K
+107.42%
Mr. Robert J. (Rob) Ball
Mr. Robert J. (Rob) Ball
Executive Chairman, Chief Executive Officer
Executive Chairman, Chief Executive Officer
166.67K
+5.04%
Mr. Jeffrey S. Points
Mr. Jeffrey S. Points
Chief Financial Officer
Chief Financial Officer
52.45K
+39.55%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
47.67K
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
20.06K
+223.69%
Mr. Geoff B. Pardo
Mr. Geoff B. Pardo
Independent Director
Independent Director
--
--
Mr. Kevin K. Sidow
Mr. Kevin K. Sidow
Independent Director
Independent Director
--
--
Mr. Richard J. (Rick) Buchholz
Mr. Richard J. (Rick) Buchholz
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Michael A. (Mike) Carusi
Mr. Michael A. (Mike) Carusi
Independent Director
Independent Director
--
-100.00%
Name
Name/Position
Position
Shareholding
Change
Mr. Matt Ahearn
Mr. Matt Ahearn
Chief Operating Officer, Director
Chief Operating Officer, Director
282.62K
+61.24%
Mr. David L. Blue
Mr. David L. Blue
Chief Customer Experience Officer
Chief Customer Experience Officer
182.27K
+107.42%
Mr. Robert J. (Rob) Ball
Mr. Robert J. (Rob) Ball
Executive Chairman, Chief Executive Officer
Executive Chairman, Chief Executive Officer
166.67K
+5.04%
Mr. Jeffrey S. Points
Mr. Jeffrey S. Points
Chief Financial Officer
Chief Financial Officer
52.45K
+39.55%
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
47.67K
--
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
20.06K
+223.69%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
18.57%
U.S. Venture Partners
13.07%
Gilde Healthcare Partners B.V.
11.55%
Lightstone Ventures, L.P.
9.15%
Cultivate(MD) Holdings LLC
6.62%
Other
41.03%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
18.57%
U.S. Venture Partners
13.07%
Gilde Healthcare Partners B.V.
11.55%
Lightstone Ventures, L.P.
9.15%
Cultivate(MD) Holdings LLC
6.62%
Other
41.03%
Shareholder Types
Shareholders
Proportion
Venture Capital
39.43%
Investment Advisor
23.37%
Hedge Fund
7.14%
Corporation
6.62%
Investment Advisor/Hedge Fund
5.15%
Individual Investor
3.95%
Research Firm
0.16%
Endowment Fund
0.07%
Bank and Trust
0.03%
Other
14.10%
Institutional Shareholding
Updated: Fri, Sep 12
Updated: Fri, Sep 12
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
24
12.77M
62.72%
+9.43M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
3.85M
18.9%
+3.85M
+96219675.00%
Aug 29, 2025
U.S. Venture Partners
2.69M
13.23%
+2.69M
--
Jul 31, 2025
Gilde Healthcare Partners B.V.
2.38M
11.69%
+100.00K
+4.39%
Aug 01, 2025
Lightstone Ventures, L.P.
1.62M
7.95%
+1.62M
--
Jul 31, 2025
Cultivate(MD) Holdings LLC
1.36M
6.7%
+1.36M
--
Jul 31, 2025
Arboretum Ventures, Inc.
1.16M
5.72%
+166.00K
+16.64%
Aug 01, 2025
TimesSquare Capital Management, LLC
20.63K
0.1%
+20.63K
--
Aug 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Shoulder Innovations Inc?
The top five shareholders of Shoulder Innovations Inc are:
Fidelity Management & Research Company LLC holds 3.85M shares, accounting for 18.90% of the total shares.
U.S. Venture Partners holds 2.69M shares, accounting for 13.23% of the total shares.
Gilde Healthcare Partners B.V. holds 2.38M shares, accounting for 11.69% of the total shares.
Lightstone Ventures, L.P. holds 1.62M shares, accounting for 7.95% of the total shares.
Cultivate(MD) Holdings LLC holds 1.36M shares, accounting for 6.70% of the total shares.
Fidelity Management & Research Company LLC holds 3.85M shares, accounting for 18.90% of the total shares.
U.S. Venture Partners holds 2.69M shares, accounting for 13.23% of the total shares.
Gilde Healthcare Partners B.V. holds 2.38M shares, accounting for 11.69% of the total shares.
Lightstone Ventures, L.P. holds 1.62M shares, accounting for 7.95% of the total shares.
Cultivate(MD) Holdings LLC holds 1.36M shares, accounting for 6.70% of the total shares.
What are the top three shareholder types of Shoulder Innovations Inc?
The top three shareholder types of Shoulder Innovations Inc are:
Fidelity Management & Research Company LLC
U.S. Venture Partners
Gilde Healthcare Partners B.V.
Fidelity Management & Research Company LLC
U.S. Venture Partners
Gilde Healthcare Partners B.V.
How many institutions hold shares of Shoulder Innovations Inc (SI)?
As of 2025Q3, 24 institutions hold shares of Shoulder Innovations Inc, with a combined market value of approximately 12.77M, accounting for 62.72% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for Shoulder Innovations Inc?
In --, the -- business generated the highest revenue for Shoulder Innovations Inc, amounting to -- and accounting for --% of total revenue.
